Trial Profile
A PHASE III, RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO AND CYCLOSPORINE CONTROLLED STUDY OF ISA247 IN PLAQUE PSORIASIS PATIENTS (ISA05-25).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2023
Price :
$35
*
At a glance
- Drugs Voclosporin (Primary) ; Ciclosporin
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Acronyms ESSENCE
- Sponsors Aurinia Pharmaceuticals; Isotechnika
- 31 May 2011 New trial record